/PRNewswire/ Mestag Therapeutics ( Mestag ), an immunotherapy company focusing on fibroblast-immune interactions, and VIB, the leading life science research.
VIB and Surface Oncology Announce Publication in Cell Reports Revealing IL-27 Structure and the Mechanism of Action for SRF388 - read this article along with other careers information, tips and advice on BioSpace